Development of autoantibodies precedes clinical manifestations of autoimmune diseases

A comprehensive review

Wen Tao Ma, Christopher Chang, M. Eric Gershwin, Zhe Xiong Lian

Research output: Contribution to journalReview article

37 Citations (Scopus)

Abstract

The etiology of autoimmune diseases is due to a combination of genetic predisposition and environmental factors that alter the expression of immune regulatory genes through various mechanisms including epigenetics. Both humoral and cellular elements of the adaptive immune system play a role in the pathogenesis of autoimmune diseases and the presence of autoantibodies have been detected in most but not all autoimmune diseases before the appearance of clinical symptoms. In some cases, the presence or levels of these autoantibodies portends not only the risk of developing a corresponding autoimmune disease, but occasionally the severity as well. This observation is intriguing because it suggests that we can, to some degree, predict who may or may not develop autoimmune diseases. However, the role of autoantibodies in the pathogenesis of autoimmune diseases, whether they actually affect disease progression or are merely an epiphenomenon is still not completely clear in many autoimmune diseases. Because of these gaps in our knowledge, the ability to accurately predict a future autoimmune disease can only be considered a relative risk factor. Importantly, it raises the critical question of defining other events that may drive a patient from a preclinical to a clinical phase of disease.

Original languageEnglish (US)
Pages (from-to)95-112
Number of pages18
JournalJournal of Autoimmunity
Volume83
DOIs
StatePublished - Sep 1 2017

Fingerprint

Autoantibodies
Autoimmune Diseases
Regulator Genes
Genetic Predisposition to Disease
Epigenomics
Disease Progression
Immune System

Keywords

  • Autoantibodies
  • Autoimmune diseases
  • Autoimmune hepatitis
  • Environment
  • Epigenetics
  • Primary biliary cirrhosis
  • Rheumatoid arthritis
  • SLE
  • Tolerance

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Development of autoantibodies precedes clinical manifestations of autoimmune diseases : A comprehensive review. / Ma, Wen Tao; Chang, Christopher; Gershwin, M. Eric; Lian, Zhe Xiong.

In: Journal of Autoimmunity, Vol. 83, 01.09.2017, p. 95-112.

Research output: Contribution to journalReview article

@article{7fa7866ba29d46a49042b396ab55bd36,
title = "Development of autoantibodies precedes clinical manifestations of autoimmune diseases: A comprehensive review",
abstract = "The etiology of autoimmune diseases is due to a combination of genetic predisposition and environmental factors that alter the expression of immune regulatory genes through various mechanisms including epigenetics. Both humoral and cellular elements of the adaptive immune system play a role in the pathogenesis of autoimmune diseases and the presence of autoantibodies have been detected in most but not all autoimmune diseases before the appearance of clinical symptoms. In some cases, the presence or levels of these autoantibodies portends not only the risk of developing a corresponding autoimmune disease, but occasionally the severity as well. This observation is intriguing because it suggests that we can, to some degree, predict who may or may not develop autoimmune diseases. However, the role of autoantibodies in the pathogenesis of autoimmune diseases, whether they actually affect disease progression or are merely an epiphenomenon is still not completely clear in many autoimmune diseases. Because of these gaps in our knowledge, the ability to accurately predict a future autoimmune disease can only be considered a relative risk factor. Importantly, it raises the critical question of defining other events that may drive a patient from a preclinical to a clinical phase of disease.",
keywords = "Autoantibodies, Autoimmune diseases, Autoimmune hepatitis, Environment, Epigenetics, Primary biliary cirrhosis, Rheumatoid arthritis, SLE, Tolerance",
author = "Ma, {Wen Tao} and Christopher Chang and Gershwin, {M. Eric} and Lian, {Zhe Xiong}",
year = "2017",
month = "9",
day = "1",
doi = "10.1016/j.jaut.2017.07.003",
language = "English (US)",
volume = "83",
pages = "95--112",
journal = "Journal of Autoimmunity",
issn = "0896-8411",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Development of autoantibodies precedes clinical manifestations of autoimmune diseases

T2 - A comprehensive review

AU - Ma, Wen Tao

AU - Chang, Christopher

AU - Gershwin, M. Eric

AU - Lian, Zhe Xiong

PY - 2017/9/1

Y1 - 2017/9/1

N2 - The etiology of autoimmune diseases is due to a combination of genetic predisposition and environmental factors that alter the expression of immune regulatory genes through various mechanisms including epigenetics. Both humoral and cellular elements of the adaptive immune system play a role in the pathogenesis of autoimmune diseases and the presence of autoantibodies have been detected in most but not all autoimmune diseases before the appearance of clinical symptoms. In some cases, the presence or levels of these autoantibodies portends not only the risk of developing a corresponding autoimmune disease, but occasionally the severity as well. This observation is intriguing because it suggests that we can, to some degree, predict who may or may not develop autoimmune diseases. However, the role of autoantibodies in the pathogenesis of autoimmune diseases, whether they actually affect disease progression or are merely an epiphenomenon is still not completely clear in many autoimmune diseases. Because of these gaps in our knowledge, the ability to accurately predict a future autoimmune disease can only be considered a relative risk factor. Importantly, it raises the critical question of defining other events that may drive a patient from a preclinical to a clinical phase of disease.

AB - The etiology of autoimmune diseases is due to a combination of genetic predisposition and environmental factors that alter the expression of immune regulatory genes through various mechanisms including epigenetics. Both humoral and cellular elements of the adaptive immune system play a role in the pathogenesis of autoimmune diseases and the presence of autoantibodies have been detected in most but not all autoimmune diseases before the appearance of clinical symptoms. In some cases, the presence or levels of these autoantibodies portends not only the risk of developing a corresponding autoimmune disease, but occasionally the severity as well. This observation is intriguing because it suggests that we can, to some degree, predict who may or may not develop autoimmune diseases. However, the role of autoantibodies in the pathogenesis of autoimmune diseases, whether they actually affect disease progression or are merely an epiphenomenon is still not completely clear in many autoimmune diseases. Because of these gaps in our knowledge, the ability to accurately predict a future autoimmune disease can only be considered a relative risk factor. Importantly, it raises the critical question of defining other events that may drive a patient from a preclinical to a clinical phase of disease.

KW - Autoantibodies

KW - Autoimmune diseases

KW - Autoimmune hepatitis

KW - Environment

KW - Epigenetics

KW - Primary biliary cirrhosis

KW - Rheumatoid arthritis

KW - SLE

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=85025163650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85025163650&partnerID=8YFLogxK

U2 - 10.1016/j.jaut.2017.07.003

DO - 10.1016/j.jaut.2017.07.003

M3 - Review article

VL - 83

SP - 95

EP - 112

JO - Journal of Autoimmunity

JF - Journal of Autoimmunity

SN - 0896-8411

ER -